Mumbai, India and Morristown, N.J., February 16, 2021 – Enovate Biolife (Enovate) and OmniActive Health Technologies (OmniActive) announced today that enXtra®*, a proprietary extract of Alpinia galanga, has been granted a US patent for the patent application publication no. US20180221430 A1 based on the granted claims on method of use of Alpinia galanga for improved cognitive performance.
This method of use patent covers a formulation of Alpinia galanga for improvement of cognitive performance such as mental alertness and increased attention that has previously been demonstrated in five clinical studies.
“While caffeine continues to lead in the nootropic space because of its experiential benefits, consumers are still constantly looking for alternatives. Clinically backed enXtra® provides a novel, natural caffeine alternative for increased alertness and sustained attention and focus. We are thrilled that this patent will allow our customers to promote these cognitive health claims for Alpinia galanga,” says Kimberly Smith, Chief Marketing Officer at OmniActive Health Technologies.
enXtra® was also recently certified by Informed Ingredient, a Quality Assurance certification for dietary supplement manufacturing facilities, which ensures that ingredients have been tested for banned substances and comply with WADA (World Anti-Doping Agency) guidelines. The certification also guarantees that ingredients are manufactured to high quality standards.
“The patent and the Informed Ingredient certification are important steps in further building enXtra®’s unique position in the market,” says Amol Pathak, Director of Business & Strategy at Enovate Biolife.
Sabrina Di Blasio
OmniActive Health Technologies
Wright On Marketing & Communications
About OmniActive Health Technologies
OmniActive Health Technologies offers scientifically validated, sustainable, IP-protected, health benefit solutions from natural sources for customers in the dietary supplement and functional food and beverage space. OmniActive’s mission is improving lives through enhancing nutrition through branded health benefit solutions that consumers demand in top categories such as: Active Wellness & Physical Performance; Metabolic Health & Weight Wellness; Vision, Cognition & Mental Wellness; Daily Energy and Productivity Performance; and Digestion & Immune Health. Some of its leading brands include Lutemax® 2020 in the eye health market, Capsimax® in the weight management market, CurcuWIN® in the sports nutrition and active lifestyle market, Gingever for digestion and immune health, and enXtra® and Xtenergy™ in the daily energy categories. Lutemax® and CurcuWIN® are also USP certified and Non-GMO Project Verified. With an established production, sales and distribution network in Asia, Europe, North America and South America, OmniActive is well-positioned to understand the unique needs and regulatory landscapes of each market. Currently, it has manufacturing plants across India, specifically in Pune, Bengaluru and Hosur, which are FDA GMP compliant. It also maintains head offices in Mumbai, India, as well as Morristown, New Jersey.
About Enovate Biolife
Enovate Biolife develops innovative, scientifically validated botanical ingredients which help position supplement and beverage brands for success in today’s highly competitive marketplace.
About Informed Ingredient
Informed Ingredient certification provides suppliers with the assurance that their ingredients carrying the Informed Ingredient mark have been regularly tested for substances considered prohibited in sport. In addition, Informed Ingredient certification ensures that ingredients have been manufactured to high-quality standards. Responsible raw material suppliers have made Informed Ingredient part of their existing quality assurance systems to minimize the risk that their ingredient is not contaminated prior to selling. LGC is the company and laboratory behind the certification. For more information visit: